Beyond The Abstract - Extragonadal Retroperitoneal Germ Cell Tumor: Primary Versus Metastases?
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology; Prostate / Prostate Cancer
Article Date: 22 Oct 2007 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com - Primary extragonadal germ cell tumors (EGCT) are rare and account a small percentage, 2% to 5%, of all germ cell tumors. In adults, these tumors have been reported in many sites, but they arise mostly along the sagital midline. The histogenetic origin of primary extragonadal germ cell tumors is still a matter of debate and it remains uncertain whether such tumors develop primary at extragonadal sites or represent metastases of a primary testicular tumor.
Previous studies of retroperitoneal germ cell tumors have showed intratubular germ cell neoplasia (IGCN), testicular scarring or an invasive testicular tumor, suggesting that the testicular tumor was primary. Therefore, it may be important to exclude testicular pathology when treating a primary retroperitoneal germ cell tumor.
Written by David Parada D. MD, MSC, PhD, as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.
-- Link to Full Abstract
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2006 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/86210.php>
APA
http://www.medicalnewstoday.com/releases/86210.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



